The San Juan de Dios Hospital is a public hospital located in Santiago, Chile. It is part of the public healthcare network in the western portion of Santiago Metropolitan Region, providing health services to residents of Santiago, Quinta Normal, Lo Prado, Renca, Cerro Navia and Pudahuel within the borders of the city.

During the past decade, Hospital San Juan de Dios conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital San Juan de Dios" #1 sponsor was "Actelion" with 3 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored, "Windtree Therapeutics" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Hernán González" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital San Juan de Dios" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Fund for Clinical Cardiovascular Research at LRD" with 1 trials as a collaborator, "Life Sciences Research Partners" with 1 trials as a collaborator, "Terry Fox Foundation" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital San Juan de Dios" are "Coronary Artery Disease" (2 trials), "Pulmonary Arterial Hypertension" (2 trials), "Respiratory Distress Syndrome" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Hospital San Juan de Dios" in a lesser frequency.

Most popular intervention types in "Hospital San Juan de Dios" are "Drug" (9 trials), "Procedure" (3 trials), "Device" (2 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "40 mg Atorvastatin/day for 120 days P.O." (1 trials), "Analgesia based sedation in ICU patients" (1 trials), "Asacol" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital San Juan de Dios" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital San Juan de Dios". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital San Juan de Dios, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital San Juan de Dios, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".